CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Clal Biotechnology Industries Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Clal Biotechnology Industries Ltd.
Azrieli Center
Triangle Building 45th flr.
Phone: +972 36121616p:+972 36121616 TEL AVIV-YAFO, 67023  Israel Ticker: CBICBI

Business Summary
Clal Biotechnology Industries Ltd (CBI) is an Israel-based biotechnology investment company. CBI's investments are targeted at bio-pharmaceutical companies, which are at different stages of research and development. The Company is a 59%-owned subsidiary of Clal Industries and Investments Ltd. (CII) that is part of IDB group. Clal Biotechnology Industries Ltd. has a number of portfolio companies, namely Andromeda Biotech Ltd., engaged in the field of type 1 diabetes; D-Pharm Ltd and Trombutech, engaged in the field of ischemic stroke; Mediwound Ltd., engaged in burn and wound management; Biokine Ltd, Biocancell Ltd and CureTech, engaged in the field of cancer; Braintact, engaged in the CNS field and Polyheal Ltd, engaged in wound management, among others.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
6799 Investors, not elsewhere classified

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Avraham M.Fischer 58 9/15/2003 9/15/2003
President, Chief Scientific Officer JulianAdams 68 1/23/2017 1/23/2017
Chief Executive Officer OferGonen 49 3/5/2017 9/1/2003
8 additional Officers and Directors records available in full report.

Business Names
Business Name
CBI
Clal Biotechnology Industries Ltd.

General Information
Number of Employees: 194 (As of 12/31/2020)
Outstanding Shares: 156,846,200 (As of 6/30/2023)
Stock Exchange: TLV
Fax Number: +972 36124545


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024